INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 23, 2005 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 17,098 | $13.31 | 37,268 |
| Aug 28, 2012 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 17,099 | $145.70 | 76,005 |
| Jan 12, 2012 |
Director
Trans History: 524
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 17,100 | $79.09 | 67,355 |
| Nov 29, 2012 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 17,155 | $181.19 | 56,946 |
| Dec 19, 2012 |
Director, EVP CSO Pres Regen Res Labs
Trans History: 628
|
Director, EVP CSO Pres Regen Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | $11.64 | 1,099,101 |
| Dec 19, 2012 |
Director, EVP CSO Pres Regen Res Labs
Trans History: 628
|
Director, EVP CSO Pres Regen Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | -- | -- |
| Nov 30, 2012 |
SVP Res and Devel Sciences
Trans History: 660
|
SVP Res and Devel Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 17,182 | $181.01 | 41,939 |
| Nov 14, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | $11.64 | 67,532 |
| Nov 14, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | -- | -- |
| Dec 19, 2005 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.